Condensed Consolidated Statements of Operations - USD ($)	3 Months Ended
	Mar. 31, 2017	Mar. 31, 2016
Operating expenses
Research and development	$ 130,762	$ 83,333
Selling, general and administrative	521,218	340,669
Total operating expenses	651,980	424,002
Loss from operations	(651,980)	(424,002)
Other expenses	3,303	2,573
Net loss	(655,283)	(426,575)
Net loss attributable to the non-controlling interest	(75,159)
Net loss attributable to the controlling interest	$ (580,124)	$ (426,575)
Net loss attributable to controlling interest per share:
Basic and diluted	$ (0.04)	$ (0.03)
Weighted average common shares outstanding	14,045,264	13,187,544